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Abstract
Human lung epithelial cells are likely among the first targets to encounter invading severe acute respiratory syndrome-
associated coronavirus (SARS-CoV). Not only can these cells support the growth of SARS-CoV infection, but they are also
capable of secreting inflammatory cytokines to initiate and, eventually, aggravate host innate inflammatory responses,
causing detrimental immune-mediated pathology within the lungs. Thus, a comprehensive evaluation of the complex
epithelial signaling to SARS-CoV is crucial for paving the way to better understand SARS pathogenesis. Based on microarray-
based functional genomics, we report here the global gene response of 2B4 cells, a cloned bronchial epithelial cell line
derived from Calu-3 cells. Specifically, we found a temporal and spatial activation of nuclear factor (NF)kB, activator protein
(AP)-1, and interferon regulatory factor (IRF)-3/7 in infected 2B4 cells at 12-, 24-, and 48-hrs post infection (p.i.), resulting in
the activation of many antiviral genes, including interferon (IFN)-b,- ls, inflammatory mediators, and many IFN-stimulated
genes (ISGs). We also showed, for the first time, that IFN-b and IFN-ls were capable of exerting previously unrecognized,
non-redundant, and complementary abilities to limit SARS-CoV replication, even though their expression could not be
detected in infected 2B4 bronchial epithelial cells until 48 hrs p.i. Collectively, our results highlight the mechanics of the
sequential events of antiviral signaling pathway/s triggered by SARS-CoV in bronchial epithelial cells and identify novel
cellular targets for future studies, aiming at advancing strategies against SARS.
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Introduction
Severe acute respiratory syndrome (SARS), caused by a novel
human coronavirus (CoV), has established itself as a fatal human
respiratory disease [1,2,3,4]. SARS-CoV is transmitted through
virus-laden droplets, and likely also via either the aerosol or fecal-
oral routes, with the lungs as its main pathological target. While the
exact mechanism of SARS pathogenesis remains unknown,
pathological examination of lung biopsies and autopsy specimens
from SARS patients revealed ‘‘diffuse alveolar damage’’ of varying
stages and severities, with extensive disruption of epithelial cells and
accumulation of reactive macrophages (MWs), accompanied by the
presence of hemophagocytic syndrome in patients who succumbed
to the disease [5,6,7,8]. Strikingly, pulmonary manifestations of
SARS patients usually occurred after the clearance of viremia and
often in the absence of other opportunistic infections. Taken
together, these observations have led to the hypothesis that SARS
pathogenesis might stem from ill-regulated and often excessive
inflammatory responses within the lungs [5]. The likelihood of
SARS being an immune-mediated disease was further supported by
reports, within the circulation and the lungs of patients affected by
SARS, of highly elevated expressions of various inflammatory
mediators, including interleukin (IL)-1, -6, -8; CXCL-10/Interfer-
on-inducible Protein (IP)-10; CCL2/Monocyte Chemoattractant
Protein (MCP)-1; CCL5/Regulated on Activation, Normal T
Expressed and Secreted (RANTES); and CXCL9/Monokine
Induced by interferon-Gamma (MIG) [9,10,11,12,13,14]. Such an
exacerbated cytokine response was subsequently demonstrated in
experimentally infected mice, especially those transgenically
expressing human angiotensin-converting enzyme 2 (hACE2) viral
receptor [15,16,17].
In contrast to the prominently elevated cytokine response, it has
been rather challenging to detect any significant response of type I
IFNs in individuals and mice infected by SARS-CoV [14,15,16].
Such a failure of SARS-CoV in inducing readily detectable type I
IFN responses was subsequently demonstrated in many in vitro
studies by using various cell types of non-pulmonary origins,
including African green monkey kidney cells (Vero cells), human
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Caco-2 cells, hepatoma Huh7 cells, and embryonic kidney (HEK)
293 cells [14,18,19,20,21]. Because type I IFNs have been shown to
be effective against SARS-CoV infection, both in vitro and in vivo
[22,23,24,25,26], the deficient response of type I IFNs in infected
hosts has led to the hypothesis that SARS-CoV has evolved
strategies to evade this potent IFN-related innate antiviral response.
Indeed,itwassubsequentlydemonstratedthat SARS-CoV-encoded
ORF3b, ORF6, ORF7, nucleocapsid (N), nsp1, and, most recently,
that membrane (M) [27] proteins could function as antagonists of
the host antiviral defenses by interrupting the IRF-3-STAT axis
of the IFN-related antiviral pathway, promoting degradation of
cellular RNAs, and inhibiting IFN production by interfering with
the formation of TRAF3.TANK.TBK1/IKKepsilon (e) complex,
respectively [28,29,30,31,32]. Furthermore, it has been suggested
that SARS-CoV and other members of the Group 2 CoVs, such as
mouse hepatitis virus (MHV), could effectively evade IFN-related
antiviral responses by actively avoiding the recognition of their
replicative RNAs by the host innate sensing mechanism/s [33,34].
Human airway epithelium is likely one of the initial sites of
SARS-CoV infection [35]. In addition to functioning as physical
and mechanical barriers that separate and eliminate inhaled
harmful infectious and non-infectious materials, lung epithelial
cells can directly respond to respiratory infections by secreting
various molecules that serve to initiate, amplify, and/or sustain
host inflammatory responses [36,37]. In this regard, we have
recently shown that IL-6 and/or IL-8 released by SARS-CoV-
infected human bronchoepithelial Calu-3 cells could exacerbate
host innate inflammatory responses, in part, by modulating the
intrinsic functions of macrophages (MW) and dendritic cells (DC)
[38]. Thus, a thorough understanding of how human lung
epithelial cells respond to SARS-CoV infection is crucial, not
only for advancing our knowledge of SARS pathogenesis, but also
for identifying novel and highly valuable cellular targets for
innovative interventions against SARS.
The scarcity of and, most importantly, the highly heterogeneous
nature of normal human bronchial epithelial (NHBE) cells with
regard to their ACE2 expression and, thus, permissiveness to
SARS-CoV infection [39,40] (Tseng, C.K. et al., unpublished
observation) greatly limits their use in exploring the genome-wide
responses to viral infections. Although human bronchial epithelial
Calu-3 cells, like NHBE cells, are heterogeneous, their availability
and well-characterized interaction with SARS-CoV [41] make
them a better choice than NHBE cells to underscore the innate
antiviral signaling pathway/s induced by SARS-CoV in patho-
logically relevant cells. However, the fact that only up to 30% of
Calu-3 cells expressed ACE2 at different intensities [41]
compromises their usefulness in underscoring host innate antiviral
signaling pathway(s) explicitly triggered by SARS-CoV. To
overcome this, we established clonal derivatives of Calu-3 cells
by standard limiting dilution. Based on their intense, homoge-
neous, and, most importantly, stable expression of ACE2 over
various passages, we chose the 2B4 clone to explore the innate
epithelial signaling pathway/s elicited by SARS-CoV by micro-
array-based functional genomics. Here, we have analyzed the
global gene responses of 2B4 cells over time in response to SARS-
CoV infection. In an attempt to clarify the characteristics of the
innate antiviral responses triggered by SARS-CoV, we also
simultaneously analyzed the gene expression profile of 2B4 cells
infected by Dhori virus (DHOV), an orthomyxovirus known to
productively infect 2B4 cells, leading to profound production of
IFNs and other inflammatory cytokines (Hill, et al., manuscript in
preparation). Contrary to the prevailing in vitro studies emphasiz-
ing the lack of readily detectable IFN responses, we find that 2B4
cells can mount an active response. However IRF-3/7-mediated
IFN-b and, especially, IFN-l responses were delayed, relative to
those of NFkB- and/or AP-1 (ATF2/c-Jun)-mediated proinflam-
matory responses, at both the transcriptional and translational
levels. The ability of 2B4 cells to activate IFN-related signaling
pathway/s in response to SARS-CoV infection is further verified
by the subsequent expression of many interferon-stimulated genes
(ISGs). While SARS-CoV infection was capable of activating the
aforementioned genes related to innate antiviral responses, the
magnitude of their expression was noticeably not as high as those
induced by DHOV. We also noticed that the translational
machinery for IFN-b and IFN-l2 mRNA transcripts in 2B4 cells
was not as efficient as those of IFN-l1, IL-6, IL-8, and, especially,
CXCL-10/IP-10. Interestingly, such a SARS-CoV-associated
inefficiency in translating genes encoding for IFN-b, IFN-l1,
and IFN-l2 was not observed in DHOV-infected 2B4 cells.
Finally, we found, for the first time, that IFN-l1 and/or -l2 (Type
III IFNs) exert a protective role, either alone or in combination
with an otherwise ineffective IFN-b, against SARS-CoV in a dose-
dependent manner. Taken together, these data offer compelling
evidence that human bronchial epithelial cells are capable of
promoting active, but delayed, IFN-related antiviral responses,
thus providing new insight into SARS pathogenesis.
Results
Establishment and Characterization of 2B4 Cells and
Their Susceptibility to SARS-CoV Infection
We employed the standard limiting dilution technique to
establish clonal derivatives of Calu-3 cells, as described in
Materials and Methods. Based on their ACE2 expression and
permissiveness to productive SARS-CoV infection, 18 out of a
total of 26 clones established exhibited an array of varying
intensities of ACE2 expression and permissiveness to SARS-CoV,
ranging from intermediate-to-low levels, whereas the remaining
eight clones revealed increased ACE2 expression and susceptibility
to SARS-CoV infection, when compared to their parental Calu-3
cells (data not shown). Among those clones that were highly
permissive to SARS-CoV, we chose cells of the 2B4 clone for a
detailed characterization with regard to the stability of ACE2
expression over different passages and the susceptibility to
productive SARS-CoV infection. As shown in Figure 1A, results
of IHC staining revealed that the ACE2 expression of 2B4 cells
(passage #6) was much more intense than that of the parental
Calu-3 cells. Such an enhanced ACE2 expression of 2B4 cells,
relative to Calu-3 cells, was confirmed by Western blot analysis
(Figure 1B). Importantly, the trend of the intense ACE2 expression
of 2B4 cells appeared to be stable, as cells derived from two
different passages (i.e., #6 and #12) exhibited little difference, if
any, in the expression of ACE2 protein. The parental Calu-3 cells,
wich originated from a human pulmonary adenocarcinoma, have
been well characterized as non-ciliated human bronchial epithelial
cells with the expression of many markers of serous gland cells and
the formation of tight junction (TJ) complexes [41,42,43,44]. The
morphology of 2B4 cells grown in the membrane inserts was
subsequently examined by TEM. As shown in Figure 1C, 2B4
cells, like parental Calu-3 cells, appeared to have a morphology
resembling that of non-ciliated pseudostratified columnar epithe-
lial cells with the expression of microvilli on the apical surface and
the formation of TJ complexes.
The permissiveness to SARS-CoV infection of 2B4 cells
(passages #6 and #12) and Calu-3 cells was investigated over
time, and the results depicted in Figure 1D. It became clear that
infected 2B4 cells (MOI=0.1) of either passage were equally
Epithelial Response to SARS
PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8729Figure 1. Characteristics of 2B4 cells clonally derived from human bronchial epithelial Calu-3 cells. Expressions of the viral ACE2
receptor in indicated passages of 2B4 cells and their parental Calu-3 cells were assessed by standard IHC (A) and Western blot analysis (B), whereas
the morphological features of polarized 2B4 cells were assessed by TEM (C), as described in Materials and Methods. The images were taken at 6,270
magnifications. The scale bar represents 1 mm. To compare the permissiveness of 2B4 cells to their parental Calu-3 cells, confluent 2B4 cells, at
passages #6 and #12, and Calu-3 cells were subjected to SARS-CoV (MOI=0.1). The growth kinetics of SARS-CoV in culture supernatant and
proportion of SARS-CoV-infected 2B4 cells were assessed at indicated time points by the standard Vero E6-based infectivity assay of the resulting cell-
free supernatants (D) and infectious center assay (E). Finally, 2B4 cells (passage #6) were infected with SARS-CoV (MOI=0.1) for 24, 48, and 72 hrs
before being fixed with 4% paraformaldehyde for monitoring the morphological changes of infected cells, as visualized by the expression of SARS-
CoV NP protein (red) by using the standard IHC (F).
doi:10.1371/journal.pone.0008729.g001
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progeny viruses than their parental Calu-3 cells. The kinetics of
viral replication in 2B4 cells (passage #8) were also evaluated by
the infectious center assay, as well as the standard IHC to estimate
the percentage (%) of infected cells and examine the morpholog-
ical changes of infected cells, respectively. As shown in Figure 1E,
infected cells gradually increased from 12 hrs (i.e., ,8%) to 24 hrs
(i.e., ,30%), reaching 100% at 48 hrs. Similarly, the expression of
the SARS-CoV N protein, as revealed by the IHC, was readily
detectable in infected 2B4 cells at 24 hrs, significantly increased at
48 hrs, and reached the maximum at 72-hrs p.i., accompanied by
the appearance of rounded and enlarged cells (CPE) (Figure 1F),
some of which became detached from the culture vessel (data not
shown). Taken together, these results indicated that 2B4 cells are
homogeneous with regard to their stability of ACE2 expression
and permissiveness to SARS-CoV infection, thereby providing a
sensitive, pathologically relevant in vitro model for characterizing
the host innate antiviral signaling pathway/s explicitly triggered by
SARS-CoV.
Global Gene Expression of 2B4 Cells in Response to
SARS-CoV Infection
We employed a cDNA microarray to analyze the patterns of the
global gene expression of 2B4 cells in response to SARS-CoV, as
the first step to explore the likely antiviral signaling pathway/s. To
ascribe unique properties of SARS-CoV-induced innate responses
(if any), it would be ideal to compare to those elicited by another
strain of human coronavirus (HCoV), e.g., 229E and OC43.
Unfortunately, neither HCoV-229E nor -OC43 could produc-
tively infect Calu-3 cells (data not shown), making such a
comparison unlikely. Because DHOV, a proposed orthomyxoviral
surrogate of the highly pathogenic avian influenza H5N1 virus
[45,46], productively infected 2B4 cells, resulting in highly intense
secretion of Type I IFN and other innate inflammatory mediators
(Hill et al., unpublished data), we compared the global gene
expression of 2B4 cells in response to SARS-CoV versus DHOV.
While the microarray-based analysis of the temporal gene
expression of 2B4 cells in response to SARS-CoV or DHOV
infection has been performed simultaneously within the same
experimental setting, most of the results relevant to DHOV
infection, unless indicated otherwise, are the subject of a separate
manuscript (Hill et al. in preparation). More specifically, we were
particularly interested in comparing virally induced genes that are
either encoding for or relevant to the expression of IFN and other
inflammatory cytokines as SARS pathogenesis has been proposed
to stem from the combination of barely detectable, if any, IFN and
exacerbated cytokine responses in patients severely affected by
SARS-CoV infection [14,47].
The temporal expression of host genes was determined by
comparing the relative abundance of specific mRNA in mock
versus SARS-CoV-infected versus DHOV-infected 2B4 cells
(MOI=0.1), harvested at 12, 24, and 48 hrs p.i. The micro-
array-based study of global gene responses was performed in
triplicate for each time point, yielding 27 arrays for analysis. Only
those genes whose expressions were significantly modulated (i.e.,
1.5-fold and p,0.05, when compared to those of mock-infected
controls) in all of the replicates (N=3) analyzed at each time point
were selected for further investigation. The kinetics of viral
replication was also determined at each time point to correlate the
levels of viral infection to the extent of host gene responses. We
constructed a Venn diagram, based on the results of the stringent
microarray analysis, to roughly reflect the temporal changes in the
gene expression of SARS-CoV-infected 2B4 cells. As shown in
Figure 2A–B, we identified a total of 178 and 239 genes whose
expression was significantly up- or down-regulated in infected 2B4
cells over time (i.e., 12–48 hrs), respectively. The capacity of
SARS-CoV to modulate gene expression of infected 2B4 cells was
not as potent as that of DHOV, whose infection resulted in 684
and 246 genes being significantly up-regulated and down-
regulated, respectively (data not shown).
Among this total of SARS-CoV-regulated 417 genes (i.e., 178
up- and 239 down-regulated genes), only 8 up-regulated genes
were detected at the earliest time point (i.e., 12 hrs). The
expression of these genes continued to increase over time and
reached the highest magnitude at 48 hrs. Functional and signaling
pathway analysis of these early, virally induced and persistent host
Figure 2. Temporal and overlapping gene expression of 2B4 cells triggered by SARS-CoV infection. Confluent 2B4 cells grown in T-75
flasks were infected with SARS-CoV at MOI=0.1 or remained uninfected (as controls). The cells were lysed for extracting total RNAs for the
subsequent microarray analysis by using Affymetrix Genechips. After the stringent pairwise comparisons and the statistical analysis, genes whose
expressions were significantly altered (e.g., fold-change $1.5 and at least 50% greater in magnitude than any change observed between control
samples, p,0.05) in SARS-CoV-infected versus uninfected 2B4 cells were selected for the additional analyses, as described in Materials and Methods.
Two Venn diagrams were created to reflect the temporal and overlapping expressions of those up-regulated (A) and down-regulated genes (B),
respectively.
doi:10.1371/journal.pone.0008729.g002
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whose function is largely associated with the regulation of innate
inflammatory responses, the remaining seven genes (i.e., ATF3,
EGR1, c-JUN, c-Fos, MKP-1, EGR4, and IKBa) are functionally
related to transcriptional factors (TFs) by acting either as
suppressors, phosphatases, or kinases (Table 1). Besides these
early activated genes, there were a total of 85 and 412 genes whose
expressions were significantly altered (i.e., either up- or down-
regulated) at 24- and 48-hrs p.i., respectively.
Identification of TFs Involved in Regulating the Temporal
Gene Expression of 2B4 Cells Triggered by SARS-CoV
TFs regulate gene transcription and play critical roles in various
biological processes, including host innate responses against
invading pathogens. The majority of TFs are also known to
regulate the expression of multiple and often overlapping genes.
The inferred activation of key TFs during the early phase of SARS-
CoV infection (i.e., 12 hrs) (Table 1) prompted us to analyze the
temporal activation of TFs by using the transcription factor
database, known as TRANSFAC. Among those TFs deduced to
be activated at 12 hrs, activation of NFkB, STAT, and Elk-1
persisted throughout the entire course of infection (i.e., 12–48 hrs),
thereby suggesting their close role in regulating epithelial responses
to SARS-CoV infection (Table 1 and Figure 3). Significant
activation of other TFs belonging to either the AP-1 family (e.g.,
ATF2, ATF2/c-JUN, and ATF3) or the CREB/ATF family (e.g.,
CREB, and CREB/ATF) were also detected at 24 hrs, whereas
activationofIRF-7,a moleculecritically involvedinthe inductionof
type I IFNs, could not be observed until 48 hrs p.i. (Figure 3).
Characterization of the Biological Functions of SARS-CoV-
Altered Genes
To identify functional patterns that might allow us to better
understand the biological relevance of the temporally regulated
genes of infected 2B4 cells, all of the significantly up- and down-
regulated genes were subjected to gene ontogeny (GO)-based
annotation and functional analysis. Those that were applicable,
namely the enriched GO terms of genes analyzed, are depicted as
Figures 4 and 5, according to their molecular function and
biological process, respectively.
All of the functionally enriched GO terms identified thus far for
those genes up-regulated at 24 and 48 hrs p.i. appeared to be
closely involved in either genomic transcription (i.e., TFs,
sequence-specific DNA and/or double-stranded RNA binding,
oligopeptide transporter, and protein dimerization) or inflamma-
tory responses (Figure 4A). The initial activation of genes encoding
inflammatory cytokines and/or chemokines was detected first at
24 hrs, and their expressions were further enhanced at 48 hrs. In
contrast, the activities of peptidyl-dipeptidase A, i.e., angiotensin
converting enzyme (ACE) and ACE2 (i.e., SARS-CoV receptor) of
infected 2B4 cells were significantly reduced at 24 hrs (Figure 4B).
Because ACE2 has a protective function against acute lung injury
[48], its reduced expression as the consequence of SARS-CoV
infection might worsen the pathogenesis resulting from SARS-
CoV infection. While the expressions of genes functionally related
to oxidoreductase were also reduced at 48 hrs, their subsequent
impact on the host responses and/or SARS pathogenesis remains
currently unknown.
When these significantly modulated genes were analyzed,
according to the biological process, we could not identify any
enriched GO terms for those genes whose expressions were down-
regulated over time. In contrast, we were able to assign 13
enriched GO-annotated terms that describe the ‘‘biological
themes’’ of those genes whose expressions were up-regulated in
infected 2B4 cells (Figure 5). Among these 13 annotations of the
biological entities, the expressions of genes directly involved in the
process of cell differentiation, cell cycle progression, and cell-to-cell
signaling were significantly up-regulated as early as 12 hrs and
remained highly elevated at 24 and 48 hrs p.i., whereas genes
highly relevant to host immune responses were not induced until
48 hrs p.i.. Interestingly, the highly elevated expressions of genes
with the GO-annotated biological functions of ‘‘response to virus’’
and ‘‘immune response’’ were particularly prominent, as support-
ed by the extremely low P values.
It is thought that SARS pathogenesis likely stems, in part, from
ill-regulated and often excessive innate inflammatory responses
against respiratory SARS-CoV infection. To more relevantly
measure the possible impact that infected lung epithelial cells
might have on temporal host immune responses in vivo,w e
generated heat maps of two elevated gene sets of infected 2B4 cells,
representing immune responses/response to virus (N=52), and
Table 1. Common up-regulated genes in 12, 24 and 48 hrs.
Gene symbol Name Function TF
a Fold increase
12hrs 24hrs 48hrs
ATF3 Activating transcription factor 3 Transcription factor in ATF/CREB family Elk-1 1.8 2.4 3.1
MKP-1 MAP kinase phosphatase 1 Negatively regulate MAPK Elk-1 1.6 2.3 3.0
EGR1 Early growth response 1 Transcription factor which may play roles in
cell growth, apoptosis and differentiation
Elk-1, NFkB, STAT 4.2 4.9 4.7
EGR4 Early growth response 4 Autoregulatory transcriptional repressor 2.1 4.4 4.9
c-FOS v-fos FBJ murine osteosarcoma viral
oncogene homolog
Dimerise with the other AP-1 to form the
AP-1 transcription factor complex
Elk-1 1.6 2.7 2.3
c-JUN v-jun sarcoma virus 17 oncogene
homolog (avian)
Dimerise with the other AP-1 to form the
AP-1 transcription factor complex
Elk-1, STAT, GABP, CCAAT 1.7 2.7 3.7
IKBa Nuclear factor of kappa light polypeptide
gene enhancer in B-cells inhibitor alpha
Inhibit NFkB nuclear translocation NFkB 1.7 3.3 5.8
PTX3 Pentraxin-related gene, rapidly induced
by IL-1b
Amplification of the inflammatory reactions
and regulation of innate immunity
1.8 4.4 10.6
aEnriched TF responsible for up-regulating the expression of genes at 12 hrs (see Fig. 3).
doi:10.1371/journal.pone.0008729.t001
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PLoS ONE | www.plosone.org 5 January 2010 | Volume 5 | Issue 1 | e8729Figure 3. Temporal and differential activation of transcription factors (TFs) in SARS-CoV-infected 2B4 cells. Genes whose expressions
were significantly altered in SARS-CoV-infected 2B4 cells were subjected to the TRANSFACdatabase-based analysis of TF activation. Adjusted p values of




Figure 4. Enriched molecular functions of those genes whose expressions in 2B4 cells were significantly altered by SARS-CoV.
Expressions of both up- and down-regulated genes at 12, 24, and/or 48 hrs after SARS-CoV infection were analyzed against the entire human
genome gene set. The enriched GO-annotated terms identified for those up-regulated and down-regulated genes are presented in A and B,
respectively. The height of an individual bar represents the level of the statistical significance of the enriched GO-annotated term. An adjusted p value
of ,0.05 was used as the criterion for selecting enriched molecular functions.
doi:10.1371/journal.pone.0008729.g004
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Figure 6A–B, genes encoding CCL20, IL-1A, IL-6, and IL-8
appeared to be among the first batch of inflammatory genes
activated by SARS-CoV at 24 hrs. The induction of these early
inflammatory genes continued to increase at 48 hrs, accompanied
by the up-regulation of other host genes relevant to innate
inflammatory and/or antiviral processes, including CXCL10,
CXCL11, IFN-b1, IFN-l1, - l 2, - l 3 and many interferon-
stimulated genes (ISGs), such as ISG20, MXs, OASs, RIG-I,
MDA-5, TLR3, STATs, etc..
Confirmation of the Elevated Transcription of IL-6-, IL-8-,
CXCL10/IP-10-, CCL5/RANTES-, and IFN-l-Encoded Genes
To determine whether transcriptional activation of genes coding
for various inflammatory mediators, especially IFN-b and IFN-ls,
could be extended to the translational levels, gamma (c)-irradiated
supernatants of mock-infected and SARS-CoV-infected 2B4
cultures (MOI=0.1) at indicated time points p.i. were subjected
to Bio-Plex, ELISA, and/or VSV/Vero-based plaque-reduction
assays for assessing the contents of cytokines, chemokines, and
IFNs. Among 35 cytokines and chemokines that could be
simultaneously measured by using the human group I and II
Bio-Plex, we were able to detect significantly elevated expression of
fibroblast growth factor (FGF) basic, CCL5/RANTES, CXCL1/
GROa, CXCL10/interferon-inducible protein (IP)-10, IL-1a, IL-
6, IL-8, platelet-derived growth factor (PDGF) BB, and
TNFSF10/TRAIL at either 48 or 72 hrs p.i. (Figure 7). We
could also detect the increased expression of IFN-b, IFN-l1, and
IFN-l2 proteins at 72 hrs by ELISA. While the induction of many
host genes could be confirmed at both transcriptional and
translational levels, the enhanced expression of genes coding for
FGF basic and PDGF BB, two molecules frequently implicated as
participating in the process of various pathological conditions,
could only be detected at the translational, but not transcriptional,
levels at 48 and/or 72 hrs p.i. Contrary to the elevated expression
of most inflammatory mediators, the production of IL-1RA, an
antagonist of IL-1a and -1b, by infected 2B4 cells was significantly
reduced as early as 24 hrs p.i. and sustained through 72 hrs p.i..
Expression Correlation between mRNAs and Their
Corresponding Proteins in 2B4 Cells
The discordant mRNA and protein expression of genes
encoding for FGF basic, PDGF BB, and, IL-1RA in SARS-
CoV-infected 2B4 cells prompted us to evaluate the correlativity of
mRNA and the corresponding protein expression among a cohort
of virally activated genes, including CCL5/RANTES, CXCL1/
GROa, CXCL10/IP-10, IFN-b, IFN-l1,IFN-l2, IL-1a, IL-6, IL-
8, and TNFSF10/TRAIL. We selected 48 hrs and 72 hrs p.i., two
of the most conspicuous time points for detecting up-regulated
mRNA and protein levels, respectively, for this analysis. We
calculated the fold-increase of either mRNA or the protein of
individual genes elicited by infected 2B4 cells over those that were
mock-infected (N=3) at the indicated time points by simply
dividing the raw values of mRNA or protein for individual genes
expressed in infected cells by those detected in mock-infected ones.
The resulting values were subjected to the Spearman correlation
coefficient analysis for establishing the interrelationship between
mRNA and protein expression of targeted genes. As shown in
Figure 8A, there existed a very strong and positive correlation
between the transcriptional and translational expressions of genes
encoding CXCL10/IP-10, IFN-l1, IL-6, TNFSF10, CCL5/
RANTES, IL-8, and CXCL1, respectively (r
2=0.8378, p,0.01).
In contrast, the levels of mRNAs and their corresponding proteins
correlated poorly for IFN-l2-, IL-1a-, and IFN-b-encoding genes,
in that the levels of mRNA transcripts were more readily
detectable than those of the proteins.
To determine whether such poor efficiency in protein
expression of IL-1a, IFN-l2, and, particularly, of IFN-b by 2B4
cells, was a unique consequence of SARS-CoV infection, we
performed a parallel analysis of the mRNA and protein expression
profiles of those genes whose expressions were significantly
activated in 2B4 cells upon infection with SARS-CoV or DHOV
by comparing the expression levels of mRNA and protein of the
targeted genes. Briefly, the relative mRNA and protein expression
efficacies of genes elicited by differentially infected 2B4 cells were
calculated by dividing the amounts of mRNA or protein detected
in SARS-CoV-infected cultures by those expressed by DHOV-
    
  
Figure 5. Enriched entities of biological processes for those genes that were highly activated in 2B4 cells in response to SARS-CoV
infection. While no enriched GO-annotated biological term could be identified for those genes whose expressions were significantly down-
regulated, 13 enriched biological entities were readily revealed for those highly activated genes of SARS-CoV-infected 2B4 cells at 12, 24, and/or
48 hrs p.i.. The height of each individual bar represents the level of statistical significance of the enriched GO-annotated biological process. An
adjusted p value of ,0.05 was used as the minimal criterion for selecting the enriched GO-annotated biological functions.
doi:10.1371/journal.pone.0008729.g005
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Figure 8B, we drew a dotted line representing a ‘‘one-to-one’’ ratio
of the gene mRNA and protein expression. Thus, genes plotted
above this dotted line would represent those whose protein
expression after mRNA transcription were more efficiently
expressed by DHOV-infected cells, whereas genes plotted
underneath the dotted lines represented those whose expression
was more readily detectable by SARS-CoV-infected cultures. It
became clear that while SARS-CoV-infected 2B4 cells were able
to retain their ability to express some of the activated genes, such
as TNFSF10, IL-8, and, especially, CXCL10/IP-10, they were
particularly inefficient in the post-transcriptional expression of
many antiviral genes, especially those encoding for IFN-b, IFN-l1,
and IFN-l2, when compared to DHOV-infected cells. Taken
together, our results lead us to suggest that SARS-CoV might have
evolved strategies, likely via preferentially targeting IFN-related
antiviral genes at post-transcription level, to successfully establish
infection in the immune-competent 2B4 cells.
Synergistic Effect of IFN-b and IFN-ls Against SARS-CoV
Replication
Type I IFNs (IFN-a/b) rapidly produced by the infected host
serves as the first line of defense against viral infections, in part,
via triggering the expressions of many ISGs to combat the
invading pathogens. The ability of SARS-CoV to activate MXs,
OAS, RIG-I, MDA5, TLR3, STATs, and many other ISGs
without stimulating any significant responses of IFN-b,a n d
especially of IFN-as, prompted us to investigate whether IFN-ls
elicited by infected 2B4 cells could potentiate IFN-a/b-like
activity against SARS-CoV. To evaluate the potential of IFN-ls
alone or in combination with type I IFNs against SARS-CoV
infection, we pretreated 2B4 cells with IFN-b,I F N - l1 and IFN-
l2, either individually or in combination at indicated concen-
trations prior to infection with SARS-CoV (MOI=0.01). While
IFN-b at the concentration of 5 ng (equivalent to 1,000 IU)
alone had a significant antiviral effect, we were unable to reveal
any antiviral effect of either IFN-l1o r- l2w h e nu s e da l o n ea ta
Figure 6. SARS-CoV-infected 2B4 cells elicit temporal and transitional expressions of genes relevant to innate immune responses.
The expression of 52 and 26 genes relevant to host viral immune responses (A) and the expression of cytokines and chemokines (B) elicited by SARS-
CoV-infected 2B4 cells were hierarchically clustered along with time points after infection to more comprehensively reveal the temporal and
transitional nature of host antiviral and inflammatory responses to SARS-CoV infection.
doi:10.1371/journal.pone.0008729.g006
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Figure 7. Confirmation of the transcription of pro-inflammatory genes at the translational level. Cell-free supernatants harvested from
mock- and SARS-CoV-infected 2B4 cultures at indicated time points p.i. were assessed for the concentration of various inflammatory mediators by
using the human group I 27-plex and group II 8-plex Cytometric Bead Array, ELISA (for IFN-b and –ls), as described in Materials and Methods.
*, p,0.05 by two-way ANOVA with Bonferroni’s post-hoc test in comparison with the mock-infected group at the same hrs p.i.
doi:10.1371/journal.pone.0008729.g007
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combinational treatment of both IFN-l1a n dI F N - l2, even at a
concentration as low as 10 ng each, significantly reduced
SARS-CoV replication (P,0.05), which suggested to us that
both types of IFN-ls are required to effectively limit the
replication of SARS-CoV (Figure 9B). Additionally, treatment
with either type of IFN-l,t o g e t h e rw i t ha no t h e r w i s ei n e f f e c t i v e
low-dose of IFN-b (e.g., 10 IU), drastically hampered the
g r o w t ho fS A R S - C o Vi n2 B 4c e l l s( P,0.05), a finding which
may imply that either species of IFN-l could potentiate the
antiviral effect of IFN-b. Surprisingly, we also found that
pretreatment of cells with all three types of IFNs together (i.e.,
IFN-l1, IFN–l2, and IFN-b) at a low-dose regimen (i.e., 10 ng
each for IFN-l1a n d– l2 and 0.05 ng for IFN-b) diminished the
antiviral effect provided by the combination treatments of IFN-
l1/IFN-b,I F N - l2/IFN-b, and IFN-l1/IFN-l2a tt h es a m e
concentrations. While the mechanism of this interesting
observation remains unknown, our results showed that IFN-ls
possess a previously unidentified type I IFN-like activity against
SARS-CoV.
Discussion
Intense acute inflammatory responses, concomitant with
extremely unremarkable IFN-a/b secretion, are the hallmark of
SARS-CoV infection. However, the molecular mechanisms
attributed to such highly dysregulated innate antiviral responses
in SARS-CoV-infected cells, especially those of pathologically
relevant lung epithelial cells, remain elusive. We have reported
that whereas human bronchial Calu-3 cells secreted high levels of
biologically active IL-6, IL-8, and IP-10 in response to SARS-CoV
infection, they failed to mount any detectable IFN-a/b response
[38]. Because Calu-3 cells are highly heterogeneous with regard to
the expression of the ACE2 viral receptor [41], we strived and
succeeded to establish various clones of Calu-3 cells, which would
be valuable for studying the host response to SARS-CoV infection.
The global host gene expression in response to SARS-CoV
infection has been previously reported in various cell types,
including the less permissive (if any) human PBMC [14,18] and
primary MW [19], highly permissive, but pathologically irrelevant
Caco-2 cells [49] and Huh7 cells [50] and even Vero E6 cells [21].
 
 
Figure 8. Correlation between transcript and protein levels of genes encoding chemokines, cytokines and IFNs. The relative
transcriptional-versus-translational efficacies of selected genes in 2B4 cells were assessed, based on the fold-increase of mRNA and the corresponding
protein levels of infected cells over those of mock-infected ones. A strong correlation between transcriptional and translational expressions of genes
coding for CCL5/RANTES, CXCL1/GROa, CXCL10/IP-10, IFN-l2, IL-6, IL-8, and TNFSF10/TRAIL (r
2=0.8378) was identified in SARS-CoV-infected 2B4
cells. Dotted line indicates regression line (A). The relative efficacy of gene expression among those highly activated in SARS-CoV-infected and DHOV-
infected 2B4 cells was compared as described in a subsection of Results. Dotted line (y=x) separates the genes to verify which virus (DOHV; upper
part, SARS-CoV; lower part) -infected 2B4 cells effectively translate the genes than the other virus-infected one. It became clear that translational
expressions of CCL5/RANTES, CXCL1/GROa, IL-1a, IL-6, and, particularly of IFN-b, IFN-l1 and –l2 were efficient in DHOV-infected 2B4 cells. The
efficacy of CXCL-10/IP-10, IL-8 and TNFSF10/TRAIL expression was similar between these two differentially infected 2B4 cells (B). Results are showna s
mean 6 SEM for nine calculated results by division of each triplicated samples in indicated cytokines.
doi:10.1371/journal.pone.0008729.g008
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these studies has been based on a single time point after infection,
ranging from 2 to 24 hrs p.i., with the study of Huh7 cells being
the only exception in which RNA samples collected at both 2 and
4 hrs p.i. were analyzed. Based on their stable and intense ACE
expression and, thus, enhanced permissiveness to productive
SARS-CoV infection, compared to that of parental Calu-3 cells
(Figure 1), we chose the cloned 2B4 cells for studying the temporal
expression of airway epithelial genes related to the innate antiviral
defense against SARS-CoV infection by using microarray-based
functional genomics.
It has been well documented that innate antiviral signaling is
initiated upon the recognition of conserved molecular structures
shared by invading pathogens of various origin, known as
pathogen-associated molecular patterns (PAMPs), by specific
pattern recognition receptor (PRR) molecules expressed on host
cells, which ultimately leads to the activation of transcriptional
factors, primarily IRF3/7 and NFkB, for the induction of IFN-a/
b and other proinflammatory mediators [51,52,53]. By using this
in vitro system, we demonstrated that NFkB and STAT were
among the earliest TFs activated at 12 hrs. The fact that their
activation persisted throughout the entire course of infection (i.e.,
12 to 48 hrs) (Figure 3) strongly argues for their important role in
regulating epithelial responses to SARS-CoV. The critical roles of
NFkB- and STAT-mediated signaling pathways in the activation
of many ISGs and genes coding for various pro-inflammatory
mediators have been well characterized [54,55]. Although several
other TFs belonging to the AP-1 and CREB/ATF families and
their heterodimeric complexes, i.e., ATF3, CREB, CREBATF,
CRE-BP1, and CRE-BP1-c-JUN, all of which are known to
regulate the transduction of many inflammatory genes, were
subsequently activated at 24 hrs, the activation of IRF-7 did not
occur until 48 hrs p.i. (Figure 3). Such a delay in the activation of
IRF-7 relative to that of NFkB and AP-1 in 2B4 cells appeared to
be unique to SARS-CoV as it was not observed in DHOV-
infected 2B4 cells (data not shown).
The ability to rapidly synthesize and secrete type I IFNs,
especially IFN-b, is a key element of the innate antiviral responses.
Effective transcriptional induction of the IFN-b gene requires
coordinated induction and binding of at least three promoter-
specific TFs (i.e., NFkB, IRF-3, and ATF-2/c-Jun) [56,57].
Although activation of NFkB- and/or AP-1 (c-JUN/ATF2)-
mediated pathways could contribute to IFN-b gene induction
[58], studies with targeted gene knockout (KO) mice have clearly
indicated that IRF-3 and/or IRF-7 molecules play an indis-
pensible, but distinctive, role in the induction of IFN-a/b
responses against viral infection [59]. IRF-3 is constitutively
expressed in many cells, whereas the expression of IRF-7 is highly
inducible by IFNs [60,61]. It has been demonstrated that
activation of IRF-3 is primarily responsible for the early and
limited induction of IFN-a/b genes, which, in turn, bind to their
corresponding type I IFN receptors in an autocrine and/or
paracrine manner to initiate a positive feedback loop through the
induction and subsequent activation of IRF-7 for furthering IFN-
a/b production [62]. Unfortunately, the TRANSFAC database
that we used in this study to identify enriched TFs did not contain
data on IRF-3 or its regulatory binding sites, preventing us from
deducing whether IRF-3 activation was induced in 2B4 cells upon
SARS-CoV infection. However, the elevated transcriptional
activation of genes coding for IRF-7, IFN-b, IFN-ls, and many
ISGs detected at 48 hrs in infected 2B4 cells strongly argue for the
activation of IRF-3 by SARS-CoV in 2B4 cells. However, the
impact of such a delay in the activation of the indispensible IRF-3/
7 pathways, relative to those of NFkB and/or ATF2/c-Jun, in the
induction of potent, IFN-associated epithelial antiviral responses
might be of significance.
The molecular mechanism responsible for the delay of IRF-3/
7 activation in infected 2B4 cells remains unknown. However, it
has been reported that SARS-CoV is capable of evading innate
antiviral responses by encoding antagonistic molecules that target
different host antiviral pathways. Specifically, ORF3b, ORF6,




Figure 9. Efficacy of IFN-ls in the host defense against SARS-CoV infection. Confluent cultures of 2B4 cells were treated with rIFN-b, rIFN-
l1, or rIFN-l2 at the indicated concentrations alone (A) or in combination (B) for 24 hrs prior to their infection with SARS-CoV (MOI=0.01). Resulting
supernatants were harvested at day 2 after infection for assessing yields of infectious progeny virus by the standard Vero E6-based infectivity assay.
*, p,0.05 by a two-way ANOVA with Bonferroni’s post-hoc test in comparison with IFN-untreated cultures. Data shown were representative of two
independent experiments.
doi:10.1371/journal.pone.0008729.g009
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3, leading to the inhibition of IFN-b gene induction [29], whereas
SARS-CoV-encoded ORF7 and nsp1 proteins can facilitate
immune evasion by either promoting degradation or inhibiting
translation of cellular mRNA transcripts [31,63,64]. It was also
reported that SARS-CoV could directly interrupt the nuclear
translocation of activated STAT1 to prevent the induction
of IFN-mediated antiviral responses [32,65]. Finally, the ability of
SARS-CoV M protein to actively interfere with the formation of
the TRAF3.TANK.TBK1/IKKe complex, thereby inhibiting
TBK1/IKKe-dependent activation of IRF3/IRF7, is yet another
mechanism by which SARS-CoV prevents the production of
IFN-a/b [27]. Taken together, SARS-CoV appeared to
preferentially target the TBK1/IKKe-IRF-3/7-STAT axis of
the IFN-related signaling pathway, rather than inflammatory
response-bound NFkB- and/or ATF2/c-Jun pathways, to
circumvent the host innate antiviral activities. However, such
interferences in the TBK1/IKKe-IRF-3/7-STAT- signaling axis
imposed by SARS-CoV in 2B4 cells appeared to be incomplete,
as evidenced by the increased expression of many antiviral genes,
such as IFN-b,I F N - ls, and ISGs, at 48 hrs (Figure 6A–B). Thus,
like many other viruses, SARS-CoV might have established
strategies to antagonize host antiviral responses by delaying,
rather than completely blocking, IFN-related IRF-3/STAT1-
mediated signaling pathways [66].
The early and enhanced expression of CXCL-10/IP-10
(Figures 7 and 8), a potent chemoattractant for activated T cells
and NK cells [67,68] within the circulation and the lungs of
patients affected by SARS, has been associated with adverse
outcomes in SARS [11,12]. Thus, the ability of infected 2B4 cells
to retain a prominent and highly correlated transcriptional and
translational activation of the CXCL-10/IP-10 gene, but not
others (Figures 7 and 8), might be relevant to SARS pathogenesis.
In contrast, such a highly correlated mRNA-protein expression
was not observed for IFN-l2 and, especially, IFN-b. Specifically,
the expressions of IFN-l2 and IFN-b genes in SARS-CoV-
infected 2B4 cells were more readily detected at the transcriptional
rather than the translational levels (Figure 8A). Importantly, such
disparities of the post-transcription efficiency among genes tested
in this study were not inherited by 2B4 cells, as cells infected by
DHOV were quite capable of expressing transcripts and proteins
of IFN-l2 and IFN-b in a highly correlated manner (Figure 8B
and Hill, T. et al, in preparation). Taken together, these results
suggest that while the expressions of IFN-l2 and, especially of
IFN-b proteins, were profoundly inhibited, SARS-CoV infection
did not impose a generalized suppression of host posttranscrip-
tional machinery in 2B4 cells, an observation consistent with that
reported for SARS-CoV nsp-1 protein [12,64]. The failure of
effectively translating IFN-b transcripts has also been reported
recently in mouse fibroblasts infected by MHV stain A59.
Interestingly, such an inhibition of the production of IFN-b
protein appeared to occur at the post-transcriptional level without
affecting the stability of either mRNA transcripts or synthesized
protein [69].
With the exception of CXCL1 and CXCL10/IP-10, enhanced
protein levels of most of the aforementioned genes, including IFN-
b and IFN-ls, could not be convincingly detected until 72 hrs p.i.
(Figure 7); however, transcripts of many ISGs (e.g., MXs, OASs,
RIG-I, MDA-5, TLR3, STATs, and ISG20) were present at
48 hrs, thereby strongly arguing for the likelihood of a minute, but
physiologically relevant, amount of IFN-b and/or IFN-l proteins,
which was otherwise undetectable by the Bio-Plex, ELISA, and/or
the standard plaque reduction assay, being produced by SARS-
CoV-infected 2B4 cells early after infection.
Similar to the induction of IFN-a/b expression, virally induced
expression of IFN-ls also relies on the activation of the RIG-I-
MAVS/IPS-1-TBK1/IKKe-IRF3 signaling axis [70]. Despite
such striking similarities between these two classes of IFNs with
regard to their patterns of activation, expression, and biological
functions, it was recently reported that the virally induced
production of IFN-ls was much more intense in the stomach,
intestines, and lungs, when compared to findings in the CNS and
spleen. Furthermore, epithelial cells seemed to be preferentially
responsive to IFN-ls, when the latter results were compared to
those from other cell types, thereby leading to the suggestion that
IFN-ls exhibit some tissue and cell specificity [71]. Recent studies
that compared the role of IFN-a/b and IFN-ls in the host innate
immunity against respiratory influenza A virus versus hepatotropic
Thogotovirus in IFN receptor knockout mice have indicated that
IFN-ls contribute to the host defense viral pathogens infecting the
lung but not the liver, further emphasizing a tissue-restricted
manner of IFN-l-mediated antiviral responses [72]. Thus, the use
of human bronchial epithelial 2B4 cells may be responsible for our
success in identifying highly elevated expressions of IFN-l genes as
a novel biomarker of SARS-CoV infection.
While the efficacy of IFN-a/b in prophylaxis against SARS-
CoV infection has been well established, the relative contribution
of IFN-ls in the epithelial defense against SARS-CoV infection
has yet to be explored. Here, we showed that SARS-CoV
replication could be drastically inhibited by IFN-ls (i.e., IFN-l1
and -l2), when used together, even at a low dose (10 ng per each
of l1, ,0.3 IU and l2 ,0.2 IU), but not when either IFN was
used alone, even at a high dose (1,000 ng per each of l1 ,30 IU
and l2 ,20 IU), to treat 2B4 cells for 24 hrs before viral challenge
(MOI=0.01). Furthermore, the combined IFNls inhibited the
replication by a factor of ,100 to a level comparable to that
exerted by 5 ng (,1,000 IU) of IFN-b. Furthermore, either type of
IFN-ls, when used at a concentration of 100 ng (i.e., ,3 and 2 IU
of l1 and l2, respectively), but not at 10 ng, when combined with
an otherwise ineffective dose of IFN-b (i.e., 0.05 ng/10 IU), could
highly potentiate antiviral responses, resulting in the reduction of
SARS-CoV replication by a factor of ,50–75 at day 2 after
infection (Figure 9). While the efficacy of IFN-ls against SARS-
CoV replication, when used alone or in combination with IFN-b,
has been consistently observed in our studies, additional in vitro and
animal studies are warranted to determine the mechanism(s) of
protection and whether type I and type III IFNs exert a
redundant, complementary, or synergistic role in the host defense
against SARS-CoV infection.
In summary, we demonstrated that human bronchial epithelial
2B4 cells are capable of responding to SARS-CoV infection by
temporally activating latent NFkB (12-hrs), AP-1 (ATF2/-Jun) (24-
hrs), and IRF-3/7 (48-hrs), all of which, especially IRF-3/7, are
critically involved in the induction of type I IFN gene expression
and the subsequent activation of virus-dependent and/or IFN-
dependent antiviral signaling pathways. Early activation of NFkB
and AP-1 in epithelial cells would lead to the production of
inflammatory mediators, especially IL-6 and IL-8, which have the
potential to exert detrimental effects on the host immune response,
in part, by modulating the intrinsic functions of resident MW and
DCs [38]. Furthermore, because IRF-3/7 play an indispensible
role for the induction of the optimal expression of type I IFNs,
their delayed activation, relative to NFkB and AP-1, would likely
postpone the onset of type I IFN-mediated innate antiviral
responses, thereby greatly compromising the ability of the infected
host to keep early viral replication in check. Despite their delayed
expressions, we demonstrate, for the first time, that both IFN-a/b
and IFN-ls possess non-redundant and, therefore, complementary
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ISGs elicited by lung epithelial cells, the primary target cells of
SARS-CoV infection, which might be crucial targets for not only
better understanding the initiation of innate and adaptive




Vero E6 cells [CRL-1580, American Type Culture Collection
(ATCC)] were grown in Eagle’s minimal essential medium (MEM)
supplemented with 10% fetal calf serum (FCS), designated M-10
medium, whereas human bronchial epithelial Calu-3 cells (HTB-
55, ATCC) were grown in MEM medium supplemented with
20% FCS (M-20) medium. Calu-3 cells, which originated from a
human pulmonary adenocarcinoma, have been well characterized
as non-ciliated human bronchial epithelial cells with a mixed
phenotype and have been used in many areas of biomedical
research since their establishment.
Viruses
The Urbani strain of SARS-CoV, kindly provided to us by Dr.
T. G. Ksiazek at the Center for Disease Control and Prevention
(Atlanta, GA), was used throughout this study. The original stock
of SARS-CoV was subjected to two additional passages in Vero
E6 cells. A viral stock with a titer of 1610
7 50% tissue culture
infectious doses (TCID50)/ml was generated and stored at 280uC.
The prototype strain (IG 611313) of Dhori virus (DHOV), an
orthomyxovirus, was also used in this study. Although DHOV was
originally isolated from Hyalomma dromedarii ticks [73], intranasal
infection of mice with this tick-borne virus resulted in the onset of
a fulminant and uniformly fatal illness with many of the clinical,
inflammatory, and pathologic features highly resembling to those
observed in mice infected with H5N1 highly pathogenic avian
influenza A virus (i.e., H5N1) [45,46]. The original stock of
DHOV, provided by Dr. Bob Tesh (Department of Pathology,
UTMB), was subjected to three additional passages in Vero E6
cells before being used in this study.
All experiments involving infectious DHOV and SARS-CoV
were conducted at UTMB in approved biosafety level-2 and -3
laboratories, respectively.
Establishing and Characterizing the Clonal Derivatives of
Calu-3 Cells
To establish Calu-3 cell populations homogeneously expressing
ACE2 at a given intensity, we performed standard limiting dilution
assays. Briefly, the single-cell suspension of the parental Calu-3
cells was subjected to serial 10-fold dilutions with M-20 medium,
followed by cultivation in 96-well microtiter plates (1 cell/well)
without the addition of feeder cells. Confluent subcultures were
transferred to 24-, 12-, and 6-well plates before further expansion
into culture flasks. Individual clones were subjected to analyses for
the expression of ACE2 and their susceptibility to SARS-CoV
infection by immunohistochemistry (IHC) and Vero E6-based
infectivity assays, respectively.
Infectious Center Assay
The infectious center assay, as described by Dutta and Myrup
[74], was used to estimate the percentage of SARS-CoV-infected
2B4 cells over time. Briefly, SARS-CoV-infected 2B4 cells
(MOI=0.1) grown on the 24-well plates were washed with
phosphate-buffered saline (PBS) at indicated time points after
infection to remove the cell-free viruses. The infected 2B4 cells
were harvested by adding Trypsin-EDTA, and next total cell
recovery was counted. Cells were further washed (26) with M-10
media, and the final washing was saved for determining the titer of
the residual ‘‘cell-free’’ viruses by the standard plaque forming
assay, as the control. The fixed numbers of ‘‘infected’’ 2B4 cells
were then transferred to confluent Vero E6 monolayers grown in
12-well plates. After incubation for ,30 min, the ‘‘infected’’ Vero
E6 monolayers were overlaid with MEM medium supplemented
with methylcellulose (1%) and FCS (2%) for three days before
fixing and staining by paraformaldehyde (4%) and crystal violet
(2%), respectively, to enumerate the plaques for determining the
percentage of infected cells at individual time points.
Western Blotting
Confluent Calu-3 and 2B4 cells grown onto 6-well plates were
lysed by the standard buffer containing proteinase inhibitor. After
removing cell debris by centrifugation, the total protein concen-
trations of the supernatants were measured by using a BCA
protein assay kit (Thermo Fisher Scientific, Rockford, IL). The
protein samples (20 mg each) were mixed with 26 NovexH Tris-
Glycine SDS sample buffer (Invitrogen, Carlsbad, CA), heat-
inactivated, fractionated by SDS-polyacrylamide gel electropho-
resis, and subjected to standard Western blot transfer to a
membrane. The membrane was tehn incubated with 2% blocking
reagent supplemented in the ECL Advance western blotting
detection kit (GE Healthcare, Piscataway, NJ) overnight, followed
by additional incubation overnight with either goat anti-human
ACE2 polyclonal antibody (0.1 mg/ml) at 4uC or mouse anti-b-
actin (1:1250; Cat #: ab6276, Abcam, Cambridge, MA). After it
was washed with TBS (36), the blotted membrane was allowed to
react for another 2 hours with an HRP-conjugated rabbit anti-
goat IgG (0.002 mg/ml; Cat #: sc-2768, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) or HRP-conjugated goat anti-mouse IgG
(0.0025 mg/ml; Cat #: ab5879, Abcam). After washing with TBS
(36), immunoreactive proteins were visualized by exposing them
to X-ray film by using the ECL Advance western blotting
detection kit according to the protocols provided by the
manufacturer.
Transmission Electron Microscopy (TEM)
Highly polarized 2B4 cells grown onto the membrane inserts
under an air-liquid phase were fixed with a mixture containing
2.5% formaldehyde, 0.1% glutaraldehyde, 0.03% trinitrophenol,
and 0.03% CaCl2 in 0.05 M cacodylate buffer (pH 7.2) for at least
2 hrs. After washing with 0.1 M cacodylate buffer, the cells were
fixed with 1% OsO4 in the same buffer, stained with 1% uranyl
acetate in 0.1 M maleate buffer (pH 5.2), dehydrated in ethanol,
and embedded in Poly/Bed 812 (Polysciences, Warrington, PA).
Before embedding, membranes were cut out, sliced into stripes,
and stacked at one side of a flat embedding mold. Semi-thin
sections were cut first, stained with toluidine blue, and examined
to choose the areas of confluent monolayers for the subsequent
ultra-thin sectioning by using a Leica-Reichert Ultracut S
ultramicrotome. After they were stained with 2% aqueous uranyl
acetate and lead citrate, the sections were examined under a
Philips 201 or CM-100 electron microscope at 60 kV.
Immunohistochemistry (IHC)
We employed the standard IHC for documenting the expression
of ACE2 and SARS-CoV infection. Briefly, SARS-CoV-infected
Calu-3 cultures grown on 24-well plates were washed with
phosphate-buffered saline (PBS), fixed in 4% paraformaldehyde
overnight, and rinsed (26) with PBS. After blocking with PBS
containing 5% bovine serum albumin for 30 min, Calu-3 cells
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nucleocapsid protein (NP) (i.e., 2 mg/ml; Cat. #: IMG-548,
IMGENEX, San Diego, CA). After washing (36) with PBS, cells
were stained with diluted (1:100), biotinylated goat anti-rabbit IgG
(DAKO, Glostrup, Denmark) at 37uC for an hour. Visualization
of NP was achieved by incubation with streptavidin-alkaline
phosphatase and naphthol-fast red substrate (DAKO).
Microarray Analysis
DNA microarray experiments were performed in the Molecular
Genomics (MG) Core Facilities at UTMB. Detailed information
about the procedures used has been posted on the MG Core
Facilities website (genomics@scms.utmb.edu). To characterize the
dynamic, spatial, and temporal changes of gene expression
induced by SARS-CoV or DHOV, confluent 2B4 cells grown in
T-75 flasks were infected with either viruses (MOI=0.1) or
remained uninfected (as a control) for 12, 24, and 48 hrs. To meet
the minimal number required for application of statistical
algorithms, we performed the study in triplicate at each time
point for mock-, and virally infected cultures, yielding a total of 27
arrays.
Briefly, supernatants were harvested from differentially treated
cultures at 12, 24, and 48 hrs p.i. for subsequent analyses of viral
yields and cytokine profiling, whereas the cells were subjected to
total RNA extraction by using an RNAqueous-4PCR kit and
following the protocol recommended by the manufacturer
(Ambion, Austin, TX). Although we did not perform this
microarray-based analysis on infected cells after 48 hrs p.i.,
supernatants of parallel 2B4 cultures infected with SARS-CoV
or DHOV for 72 hrs were harvested for profiling the inflamma-
tory responses. Purified RNA samples were sent to our core facility
for conversion to cDNA, biotin-labeled, and hybridized to 27
Affymetrix Human Genome U133 Plus 2.0 ‘‘Gene Chips’’ each of
which contained 54,675 probe set identifiers representing more
than ,47,400 transcripts that identify ,38,500 well-characterized
genes, and various internal controls (Affymetrix, Santa Clara, CA).
Mock-infected cells were compared to cells infected with either
SARS-CoV or DHOV at each time point. For comparison across
different arrays, the data for each array were normalized by
Robust Multi-chip Average (RMA) [75] using Spotfire Decision-
Site (Spotfire, Inc., Somerville, MA) and GeneSifter (VizX Labs,
Seattle, WA), and probe sets with expression values below the level
of background noise (as determined by detection p value) were
disregarded in further analyses. Results of these analyses indicated
that the RNA samples used and the data generated after
normalization were of sufficiently high quality for subsequent
analyses (data not shown).
For statistical purposes, all 27 arrays were analyzed as 18
separate groups (mock-, SARS-CoV-infected, and DHOV-infect-
ed cells at 12, 24, and 48 hrs). The GeneSifter-based normaliza-
tion was followed by pairwise comparisons of average group values
and Student’s t test with Benjamini and Hochberg correction [76].
Criteria for the selection of genes were as follows: All pair-wise
comparisons for one group versus another (e.g., mock-versus-
SARS-CoV or DHOV-infected cells at 12 hr) were expected to be
at least 1.5-fold and at least 50% greater than the fold-change
observed between any two controls (e.g., mock-infected replicate 1
versus mock-infected replicate 2 at 12 hr). Exceptions were made
for those probe sets that were significantly altered (fold change
$1.5, p value,0.05) at an earlier or later time point, with a
magnitude that exceeded the observed fold-change between
replicate controls by at least 50%. This allowed for more accurate
identification of those genes that increased or decreased in
expression levels over time but that fell below the stringent
statistical criteria at the lower transcriptional levels. In order to
ensure that results obtained from comparison of virally infected
cells were specific to infection, any probe set determined to be
significantly different in hybridization signal based on the above
criteria was further expected to have been detected as altered (fold-
change $1.5 and at least 50% greater in magnitude than any
change observed between control samples, p value #0.05)
between mock-infected and virally infected cells. In other words,
any gene with an expression level that differed between cells
infected with the two different viruses was considered as irrelevant
if not altered by either virus, as determined by comparison to
mock-infected control cells at that same time point.
Data-Mining, Gene Ontology and TF Analysis for DNA
Microarray Data
To identify the independence and/or redundancy of the gene
expression over time (i.e., 12-, 24-, and 48-hrs p.i.) and at each
time point, we produced Venn diagrams at Venny website (http://
bioinfogp.cnb.csic.es/tools/venny/index.html). For functional
profiling of selected genes, we employed FatiGo (http://www.
babelomics.org/), which is a web-based functional analysis tool to
determine whether any given cluster of genes has an enriched
biologically relevant term, when compared to other gene clusters
[77,78]. Specifically, all of the genes whose expressions were
significantly altered (i.e., both up- and down-regulated genes) in
infected 2B4 cells at each time point, when compared to those of
mock-infected cells, were analyzed against the available human
genomes to assign the most characteristic gene ontology (GO)
terms, such as the biological process and the molecular function, to
each cluster of genes. In addition, the TRANSFAC database
(http://www.gene-regulation.com/pub/databases.html) was em-
ployed for exploring transcription factors (TFs), their DNA-
binding sites, and regulated genes. For the statistical analysis, we
used Fisher’s exact test for comparing two groups of genes for
extracting the GO terms whose distribution among the groups was
significantly different. All of the p values obtained for the selected
GO terms were corrected to obtain an adjusted p value, according
to the Benjamini and Hochberg correction [76]. Adjusted p
values ,0.05 were chosen to determine the level of statistical
significance.
Profiling of Cytokine and IFN Proteins Secreted by
SARS-CoV-Infected 2B4 Cells
The biological activities of IFNs in culture supernatants were
assessed by the standard Vero E6/vesicular stomatitis virus (VSV)-
based plaque-reduction assay, as described by Langford and
colleagues [79]. Briefly, supernatants of virally infected cultures
were subjected to a serially 3-fold dilution on Vero E6 monolayer
grown on to the 96-well plates. After incubation for 24-hrs at
37uC, the cultures were washed (36) with phosphate buffered
saline (PBS) and challenged with 50 plaque-forming units (pfu) of
VSV. After absorption for an hour at 37uC, the medium was
decanted to remove unbound VSV, followed by addition of
100 ml/well of culture medium containing 1% methylcellulose.
The infected cultures were incubated for 24 hrs and subsequently
stained with crystal violet (1%) for enumerating the plaques.
Recombinant (r) IFN-b containing a specific activity of 10 IU
(International Unit) per 0.05 ng of protein (The PBL Biomedical
laboratories, Piscataway, NJ) was included in this IFN bioassay as
the standard. The titers of IFN in the test samples were expressed
as the highest dilution giving at least 50% reduction of 50 pfu of
VSV. In addition, we also titrated the contents of IFN-b and IFN-
ls in the supernatants by using the commercially available ELISA
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protocols provided by the manufacturer (PBL, Piscataway, NJ).
For profiling the cytokine responses of infected 2B4 cells, we
employed the Bio-Plex Cytometric Bead Array (BioRad, Hercules,
CA), as we previously described [38], in which both the human
group I 27-plex and the group II 8-plex (i.e., CXCL1/GROa,
CXCL9/MIG, IFN-a2, IL-1a, IL-12 (p40), IL-18, TNF-b,
TNFSF10/TRAIL) were used.
Evaluation of the Protective Efficacy of IFN-b and/or
IFN-ls Against SARS-CoV Infection
Confluent 2B4 cells were pre-treated with rIFN-b (PBL), rIFN-
l1, or IFN-l2 (Peprotech Inc., Rocky Hill, NJ) at indicated
concentrations either alone or in combination for 24 hrs before
challenging with SARS-CoV (MOI=0.01) for 72 hrs. The
resulting supernatants were harvested for assessing the yields of
the infectious progeny virus by the standard Vero E6-based
infectivity assay for assessing their potential in inhibiting SARS-
CoV replication.
Statistical Analysis
The results relative to cytokines, chemokines, IFN production
and virus titer are presented as the mean 6 standard deviation
(SD). In addition, a two-way ANOVA with Bonferroni’s post-hoc
test was used to establish statistical significance between groups
(p,0.05). The comparison of fold expression between mRNAs
and their corresponding proteins are presented as the mean 6
standard error of the mean (SEM). The correlation coefficient (r
2)
was calculated by Spearman correlation coefficient analysis for
establishing the relationship between mRNA and the correspond-
ing protein. The significance of the correlation coefficient was also
calculated from an F test.
The Microarray Data in Public Database
Our whole microarray results were deposited in Gene
Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/
projects/geo/). GSE17400 is the assigned accession number.
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